Drug Profile
Research programme: interferon therapies - Chlorogen
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chlorogen
- Class
- Mechanism of Action Interferon stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C; Liver disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Liver-disorders in USA
- 03 Aug 2007 Preclinical trials in Hepatitis C treatment in USA (unspecified route)